Perimeter Medical Imaging AI, Inc. (TSX-V: PINK, OTC: PYNKF, FSE: 4PC) – a commercial-stage medical technology company – is proud to announce its new Board of Directors Chair, Suzanne Foster. With her extensive experience and leadership, Perimeter is looking forward to taking their company to the next level.
Perimeter is pleased to announce the appointment of Suzanne Kurs-Lasky to the role of Chairman of the Board. With over 25 years of healthcare experience, Suzanne is a global leader in the industry and her expertise will be invaluable to all of Perimeter’s stakeholders. Perimeter’s CEO, Jeremy Sobotta, is looking forward to continuing to work closely with Suzanne in the pursuit of their mission to transform cancer surgery. Anthony Holler, who served as Perimeter’s Chair from 2019 to 2022, will also continue to provide strategic advice and serve as one of their directors.
I am thrilled to assume the role of Chair and aid Perimeter in furthering its remarkable technology to enhance patient outcomes and cut down on healthcare expenses. When I was undergoing breast cancer treatment, my surgeon used to say that she could take out the cancer, but the true miracles would come when she could take out the fear. I wish that with Perimeter’s technology, surgeons could reduce the likelihood of a second operation, but more importantly, decrease the fears and apprehensions of their patients.
Ms. Suzanne Foster is an accomplished global leader in the healthcare industry with over 25 years of experience. Currently, she is President of Beckman Coulter Life Sciences, holding key positions in the past such as President of Cardinal Health’s Health-at-Home and VP General Manager at Medtronic Advanced Energy. Ms. Foster is a highly educated professional, having earned a B.A. in Communication from the University of New Hampshire, an M.Ed in Psychology from Notre Dame College, a J.D. from Suffolk University Law School, and a Master of Public Health in Law and Health Policy from Harvard T.H. Chan School of Public Health. With her extensive background, she is a valuable asset in the healthcare industry.
The Company has announced that Chris Scott has stepped down as Chief Financial Officer (“CFO”) effective January 13, 2022. To fill the role, the Company has begun a formal search and appointed Russell Wagner as Interim CFO until a new CFO is appointed.
Mr. Russell Wagner is an exemplary CPA and executive with an impressive history of success in the finance, accounting, and treasury sectors of the healthcare industry. From 2003 until his retirement in 2020, he served as Executive Vice President, Chief Financial Officer, and Treasurer at Holy Redeemer Health System in Philadelphia, PA, where he had been gradually assuming higher-level VP roles in the Finance department since 1994. Before that, he worked for the certified public accounting firm of Heffler and Company for fifteen years, specializing in auditing and consulting for hospitals, nursing homes, home health agencies, physician groups, and health insurance companies. Mr. Wagner holds a Bachelor of Business Administration degree from Temple University in Philadelphia, PA.
About Perimeter Medical Imaging AI, Inc.
Perimeter Medical Imaging AI is revolutionizing the fight against cancer with their breakthrough imaging technology. Based in Toronto, Canada and Dallas, Texas, the company’s FDA-cleared Perimeter S-Series OCT system provides ultra-high-resolution, real-time, cross-sectional visualization of excised tissues at the cellular level. To further their fight against cancer, the company is developing their next-generation Perimeter B-Series OCT with ImgAssist AI and has been granted US$7.4 million by the Cancer Prevention and Research Institute of Texas. In honor of Breast Cancer Awareness Month, the company’s ticker symbol is an homage to the pink ribbon – “PINK”.
The TSX Venture Exchange and its Regulation Services Provider take no responsibility for the accuracy or adequacy of this release. Nonetheless, they remain committed to ensuring that all of the information provided is up to date and reliable.
Perimeter is proud to present its latest innovations in healthcare technology: the S-Series OCT and B-Series OCT. With these new tools, clinicians can expect to see improved patient outcomes and increased accuracy in their diagnoses. The company is also introducing ImgAssist, a powerful new image analysis software, which is designed to streamline workflows and make diagnosis faster and more accurate. With these exciting advances, Perimeter is poised to revolutionize the healthcare industry. However, there are risks and uncertainties associated with these initiatives, including potential delays in obtaining regulatory approvals and financial projections. Despite these potential risks, we remain confident that our products will ultimately deliver the desired results.